Potential impact of invasive surgical procedures on primary tumor growth and metastasis

Clinical and Experimental Metastasis

Volumn 35, Issue 4, 2018, Pages 319-331

  Alieva, Maria ^a   van Rheenen, Jacco ^b   Broekman, Marike L D ^c  

^a Department of Radiation Oncology   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Biopsy; Immune suppression; Metastasis; Tumor cell behavior; Tumor resection; Wound healing

Indexed keywords

ARTICLE; CANCER PREVENTION; CANCER SURGERY; CELL FUNCTION; CELL SURVIVAL; CELL TRANSFORMATION; CIRCULATION; EXTRAVASATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INVASIVE PROCEDURE; METASTASIS; NONHUMAN; PRECANCER; PRIMARY TUMOR; SYSTEMIC DISEASE; TUMOR BIOPSY; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR SEEDING; TUMOR VOLUME; WOUND HEALING; ANIMAL; BIOPSY; CELL GROWTH; CYTOREDUCTIVE SURGERY; DISEASE EXACERBATION; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BIOPSY; CELL GROWTH PROCESSES; CYTOREDUCTION SURGICAL PROCEDURES; DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS; NEOPLASM SEEDING; NEOPLASMS;

EID: 85046480719     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-018-9896-8     Document Type: Article

References (167)

1. McCutcheon BA et al (2016) Predictors of surgical site infection following craniotomy for intracranial neoplasms: an analysis of prospectively collected data in the American College of Surgeons National Surgical Quality Improvement Program Database. World Neurosurg 88:350–358. 10.1016/j.wneu.2015.12.068
2. Cote DJ, Dubois HM, Karhade AV, Smith TR (2016) Venous thromboembolism in patients undergoing craniotomy for brain tumors: a U.S. nationwide analysis. Semin Thromb Hemost 42:870–876. 10.1055/s-0036-1592306
3. Senders JT et al (2018) Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis. J Neurooncol 136:135–145. 10.1007/s11060-017-2631-5
4. Alieva M et al (2017) Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior. Sci Rep 7:7529. 10.1038/s41598-017-07660-4
5. Tagliabue E et al (2003) Role of HER2 in wound-induced breast carcinoma proliferation. Lancet 362:527–533. 10.1016/S0140-6736(03)14112-8
6. Al-Sahaf O, Wang JH, Browne TJ, Cotter TG, Redmond HP (2010) Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung. Ann Surg 252:1037–1043. 10.1097/SLA.0b013e3181efc635
7. Bogden AE, Moreau JP, Eden PA (1997) Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 75:1021–1027
8. Estourgie SH, Nieweg OE, Kroon BB (2004) High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg 91:1370–1371. 10.1002/bjs.4692
9. Hansen NM, Ye X, Grube BJ, Giuliano AE (2004) Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg 139:634–639. 10.1001/archsurg.139.6.634 (discussion 639–640)
10. Hobson J et al (2013) Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis. Breast Cancer Res Treat 139:391–401. 10.1007/s10549-013-2575-1
11. Lange PH, Hekmat K, Bosl G, Kennedy BJ, Fraley EE (1980) Acclerated growth of testicular cancer after cytoreductive surgery. Cancer 45:1498–1506
12. Peeters CF, de Waal RM, Wobbes T, Westphal JR, Ruers TJ (2006) Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer 119:1249–1253. 10.1002/ijc.21928
13. Stroncek JD, Reichert WM (2008) Overview of wound healing in different tissue types. In: Reichert WM (ed) Indwelling neural implants: strategies for contending with the in vivo environment. Taylor & Francis, Boca Raton
14. Sakurai M, Okamura J, Seki K, Kuroda C (1983) Needle tract implantation of hepatocellular carcinoma after percutaneous liver biopsy. Am J Surg Pathol 7:191–195
15. Lundstedt C, Stridbeck H, Andersson R, Tranberg KG, Andren-Sandberg A (1991) Tumor seeding occurring after fine-needle biopsy of abdominal malignancies. Acta Radiol 32:518–520
16. Shyamala K, Girish HC, Murgod S (2014) Risk of tumor cell seeding through biopsy and aspiration cytology. J Int Soc Prev Community Dent 4:5–11. 10.4103/2231-0762.129446
17. Diaz LK, Wiley EL, Venta LA (1999) Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol 173:1303–1313. 10.2214/ajr.173.5.10541110
18. Pierallini A et al (1999) Metastasis along the stereotactic biopsy trajectory in glioblastoma multiforme. Acta Neurochir (Wien) 141:1011–1012
19. Steinmetz MP, Barnett GH, Kim BS, Chidel MA, Suh JH (2001) Metastatic seeding of the stereotactic biopsy tract in glioblastoma multiforme: case report and review of the literature. J Neurooncol 55:167–171
20. Karlsson B, Ericson K, Kihlstrom L, Grane P (1997) Tumor seeding following stereotactic biopsy of brain metastases. Report of two cases. J Neurosurg 87:327–330. 10.3171/jns.1997.87.2.0327
21. Pinggera D et al (2017) Serious tumor seeding after brainstem biopsy and its treatment-a case report and review of the literature. Acta Neurochir (Wien) 159:751–754. 10.1007/s00701-017-3102-7
22. Silva MA et al (2008) Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 57:1592–1596. 10.1136/gut.2008.149062
23. Karwowski JK, Nowels KW, McDougall IR, Weigel RJ (2002) Needle track seeding of papillary thyroid carcinoma from fine needle aspiration biopsy. A case report. Acta Cytol 46:591–595. 10.1159/000326884
24. Warshaw AL (1991) Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 161:26–29 (discussion 29–30)
25. Leach SD et al (1995) Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery 118:472–478
26. Chang KJ (1995) Endoscopic ultrasound-guided fine needle aspiration in the diagnosis and staging of pancreatic tumors. Gastrointest Endosc Clin N Am 5:723–734
27. Wilkinson MJ et al (2015) Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival. Ann Surg Oncol 22:853–858. 10.1245/s10434-014-4059-x
28. Hwang SY et al (2016) Safety and accuracy of core biopsy in retroperitoneal sarcomas. Asia Pac J Clin Oncol 12:e174-178. 10.1111/ajco.12125
29. Berger-Richardson D, Swallow CJ (2017) Needle tract seeding after percutaneous biopsy of sarcoma: risk/benefit considerations. Cancer 123:560–567. 10.1002/cncr.30370
30. Michalopoulos NV et al (2008) Needle tract seeding after vacuum-assisted breast biopsy. Acta Radiol 49:267–270. 10.1080/02841850701775030
31. Fernandes Cabral DT, Zenonos GA, Fernandez-Miranda JC, Wang EW, Gardner PA (2017) Iatrogenic seeding of skull base chordoma following endoscopic endonasal surgery. J Neurosurg. 10.3171/2017.6.JNS17111
32. Farias JA, Laryea J, Gokden N, Kamel MH (2016) Peritoneal seeding following incomplete resection of mixed epithelial stromal tumor of the kidney: first case report. Urol Ann 8:114–117. 10.4103/0974-7796.171493
33. Ahn JH et al (2012) Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg 116:984–993. 10.3171/2012.1.JNS111560
34. Ma R et al (2018) Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery. J Neurooncol 136:395–401. 10.1007/s11060-017-2666-7
35. Lee SD et al (2013) Laparoscopic versus open surgery for stage I rectal cancer: long-term oncologic outcomes. World J Surg 37:646–651. 10.1007/s00268-012-1846-z
36. Tsivian A, Sidi AA (2003) Port site metastases in urological laparoscopic surgery. J Urol 169:1213–1218. 10.1097/01.ju.0000035910.75480.4b
37. Vergote I, Marquette S, Amant F, Berteloot P, Neven P (2005) Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma. Int J Gynecol Cancer 15:776–779. 10.1111/j.1525-1438.2005.00135.x
38. 2 insufflation: a novel approach to prevent intraperitoneal tumor spread. PLoS ONE 12:e0172097. 10.1371/journal.pone.0172097
39. 2 prevents hypothermia, peritoneal injury, and intra-abdominal adhesions during prolonged laparoscopic insufflations. J Surg Res 151:40–47. 10.1016/j.jss.2008.03.039
40. 2 pneumoperitoneum alter the ultra-structuture of the mesothelium? J Surg Res 133:84–88. 10.1016/j.jss.2005.09.032
41. van den Tol PM et al (1998) Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann Surg 227:242–248
42. Mathew G et al (1996) Wound metastases following laparoscopic and open surgery for abdominal cancer in a rat model. Br J Surg 83:1087–1090
43. Mutter D et al (1999) Increased tumor growth and spread after laparoscopy vs laparotomy: influence of tumor manipulation in a rat model. Surg Endosc 13:365–370
44. Iwamura M et al (2004) Port site recurrence of renal cell carcinoma following retroperitoneoscopic radical nephrectomy with manual extraction without using entrapment sac or wound protector. J Urol 171:1234–1235. 10.1097/01.ju.0000110611.55559.f3
45. Carpinteri S et al (2015) Peritoneal tumorigenesis and inflammation are ameliorated by humidified-warm carbon dioxide insufflation in the mouse. Ann Surg Oncol 22(Suppl 3):1540–1547. 10.1245/s10434-015-4508-1
46. Lee SW, Gleason NR, Bessler M, Whelan RL (2000) Port site tumor recurrence rates in a murine model of laparoscopic splenectomy decreased with increased experience. Surg Endosc 14:805–811
47. Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423–1437. 10.1038/nm.3394
48. Kitamura T, Qian BZ, Pollard JW (2015) Immune cell promotion of metastasis. Nat Rev Immunol 15:73–86. 10.1038/nri3789
49. Mathenge EG et al (2014) Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model. Neoplasia 16:950–960. 10.1016/j.neo.2014.09.004
50. Predina J et al (2013) Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery. Proc Natl Acad Sci USA 110:E415–E424. 10.1073/pnas.1211850110
51. Weber M et al (2015) Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas—an immunohistochemical study. Br J Cancer 113:510–519. 10.1038/bjc.2015.212
52. Luna-More S, Florez P, Ayala A, Diaz F, Santos A (1997) Neutral and acid mucins and eosinophil and argyrophil crystalloids in carcinoma and atypical adenomatous hyperplasia of the prostate. Pathol Res Pract 193:291–298. 10.1016/S0344-0338(97)80006-4
53. Ishibashi S et al (2006) Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma. Anticancer Res 26:1419–1424
54. da Silva JM et al (2014) Eosinophil depletion protects mice from tongue squamous cell carcinoma induced by 4-nitroquinoline-1-oxide. Histol Histopathol 29:387–396. 10.14670/HH-29.387
55. von Wasielewski R et al (2000) Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin’s disease, allowing for known prognostic factors. Blood 95:1207–1213
56. Szalayova G et al (2016) Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat 157:461–474. 10.1007/s10549-016-3839-3
57. Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: molecular and cellular mechanisms. J Investig Dermatol 127:514–525. 10.1038/sj.jid.5700701
58. Abramovitch R, Marikovsky M, Meir G, Neeman M (1999) Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 79:1392–1398. 10.1038/sj.bjc.6690223
59. Hofer SO, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ (1998) Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg 133:383–389
60. Okolie O et al (2016) Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model. Neuro Oncol 18:1622–1633. 10.1093/neuonc/now117
61. Chen X et al (2015) Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients. BMC Cancer 15:822. 10.1186/s12885-015-1853-1
62. Wu FP, Hoekman K, Meijer S, Cuesta MA (2003) VEGF and endostatin levels in wound fluid and plasma after breast surgery. Angiogenesis 6:255–257. 10.1023/B:AGEN.0000029410.32264.b0
63. Hormbrey E, Han C, Roberts A, McGrouther DA, Harris AL (2003) The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clin Cancer Res 9:4332–4339
64. Barbero S et al (2003) Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63:1969–1974
65. O’Brien ER, Howarth C, Sibson NR (2013) The role of astrocytes in CNS tumors: pre-clinical models and novel imaging approaches. Front Cell Neurosci 7:40. 10.3389/fncel.2013.00040
66. Weil S et al (2017) Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas. Neuro Oncol 19:1316–1326. 10.1093/neuonc/nox070
67. Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374. 10.1038/nrc1075
68. Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:263–266. 10.1016/j.cell.2006.01.007
69. Beerling E et al (2016) Plasticity between epithelial and mesenchymal states unlinks emt from metastasis-enhancing stem cell capacity. Cell Rep 14:2281–2288. 10.1016/j.celrep.2016.02.034
70. Parsa AT et al (2005) Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg 102:622–628. 10.3171/jns.2005.102.4.0622
71. Wijnenga MMJ et al (2017) Does early resection of presumed low-grade glioma improve survival? A clinical perspective. J Neurooncol 133:137–146. 10.1007/s11060-017-2418-8
72. Hoelzinger DB, Demuth T, Berens ME (2007) Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99:1583–1593. 10.1093/jnci/djm187
73. Liu L et al (2010) Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 70:3750–3759. 10.1158/0008-5472.CAN-09-3838
74. Le DM et al (2003) Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J Neurosci 23:4034–4043
75. Alieva M, Ritsma L, Giedt RJ, Weissleder R, van Rheenen J (2014) Imaging windows for long-term intravital imaging: general overview and technical insights. Intravital 3:e29917. 10.4161/intv.29917
76. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67. 10.1016/j.cell.2010.03.015
77. Hagemann T et al (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25:1543–1549. 10.1093/carcin/bgh146
78. Du R et al (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13:206–220. 10.1016/j.ccr.2008.01.034
79. Massague J (2008) TGFbeta in cancer. Cell 134:215–230. 10.1016/j.cell.2008.07.001
80. Wyckoff J et al (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64:7022–7029. 10.1158/0008-5472.CAN-04-1449
81. O’Sullivan C, Lewis CE, Harris AL, McGee JO (1993) Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 342:148–149
82. Lewis C, Murdoch C (2005) Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 167:627–635. 10.1016/S0002-9440(10)62038-X
83. Osswald M et al (2015) Brain tumour cells interconnect to a functional and resistant network. Nature 528:93–98. 10.1038/nature16071
84. Steeg PS (2016) Targeting metastasis. Nat Rev Cancer 16:201–218. 10.1038/nrc.2016.25
85. Cristofanilli M et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781–791. 10.1056/NEJMoa040766
86. Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329–340. 10.1038/nrc2375
87. Kusukawa J et al (2000) Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma. J Oral Pathol Med 29:303–307
88. Hu XC, Chow LW (2000) Fine needle aspiration may shed breast cells into peripheral blood as determined by RT-PCR. Oncology 59:217–222. 10.1159/000012164
89. Louha M et al (1999) Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology 29:879–882. 10.1002/hep.510290348
90. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S (2000) Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232:58–65
91. Papavasiliou P, Fisher T, Kuhn J, Nemunaitis J, Lamont J (2010) Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Proc (Bayl Univ Med Cent) 23:11–14
92. Pesta M, Fichtl J, Kulda V, Topolcan O, Treska V (2013) Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Anticancer Res 33:2239–2243
93. Juratli MA et al (2015) In vivo long-term monitoring of circulating tumor cells fluctuation during medical interventions. PLoS ONE 10:e0137613. 10.1371/journal.pone.0137613
94. Juratli MA et al (2014) Real-time monitoring of circulating tumor cell release during tumor manipulation using in vivo photoacoustic and fluorescent flow cytometry. Head Neck 36:1207–1215. 10.1002/hed.23439
95. Sandri MT et al (2010) Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery. Ann Surg Oncol 17:1539–1545. 10.1245/s10434-010-0918-2
96. van Dalum G et al (2015) Circulating tumor cells before and during follow-up after breast cancer surgery. Int J Oncol 46:407–413. 10.3892/ijo.2014.2694
97. Markar SR et al (2016) Significance of microscopically incomplete resection margin after esophagectomy for esophageal cancer. Ann Surg 263:712–718. 10.1097/SLA.0000000000001325
98. Rickles AS et al (2015) High rate of positive circumferential resection margins following rectal cancer surgery: a call to action. Ann Surg 262:891–898. 10.1097/SLA.0000000000001391
99. Marchegiani G et al (2015) Patterns of recurrence after resection of IPMN: who, when, and how? Ann Surg 262:1108–1114. 10.1097/SLA.0000000000001008
100. Bockhorn M, Jain RK, Munn LL (2007) Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol 8:444–448. 10.1016/S1470-2045(07)70140-7
101. Harney AS et al (2015) Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA. Cancer Discov 5:932–943. 10.1158/2159-8290.CD-15-0012
102. Angele MK, Chaudry IH (2005) Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches. Langenbecks Arch Surg 390:333–341. 10.1007/s00423-005-0557-4
103. Ni Choileain N, Redmond HP (2006) Cell response to surgery. Arch Surg 141:1132–1140. 10.1001/archsurg.141.11.1132
104. Lin E, Calvano SE, Lowry SF (2000) Inflammatory cytokines and cell response in surgery. Surgery 127:117–126. 10.1067/msy.2000.101584
105. Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA (2011) Surgery induced immunosuppression. Surgeon 9:38–43. 10.1016/j.surge.2010.07.011
106. Riccardi C, Santoni A, Barlozzari T, Puccetti P, Herberman RB (1980) In vivo natural reactivity of mice against tumor cells. Int J Cancer 25:475–486
107. Rushfeldt C, Sveinbjornsson B, Seljelid R, Smedsrod B (1999) Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense. J Surg Res 82:209–215. 10.1006/jsre.1998.5532
108. Heuff G et al (1993) Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol Immunother 37:125–130
109. Bayon LG et al (1996) Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 23:1224–1231. 10.1002/hep.510230542
110. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351–1362. 10.1056/NEJM199505183322008
111. Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M (2010) Immunosuppression following surgical and traumatic injury. Surg Today 40:793–808. 10.1007/s00595-010-4323-z
112. Cristaldi M et al (1997) Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients. Surg Laparosc Endosc 7:255–261
113. Lennard TW et al (1985) The influence of surgical operations on components of the human immune system. Br J Surg 72:771–776
114. Brune IB et al (1998) Normal T lymphocyte and monocyte function after minimally invasive surgery. Surg Endosc 12:1020–1024
115. Sietses C et al (1999) A prospective randomized study of the systemic immune response after laparoscopic and conventional Nissen fundoplication. Surgery 126:5–9. 10.1067/msy.1999.98702
116. Wu GJ et al (2005) Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity, thus reducing cellular ATP biosynthesis and migration of macrophages. Ann N Y Acad Sci 1042:168–176. 10.1196/annals.1338.019
117. Chen RM et al (2003) Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis. Anesthesiology 98:1178–1185
118. Cook EJ et al (2007) Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg 5:27–30. 10.1016/j.ijsu.2006.05.013
119. Tabuchi Y, Shinka S, Ishida H (1989) The effects of anesthesia and surgery on count and function of neutrophils. J Anesth 3:123–131. 10.1007/s0054090030123
120. Spiegel A et al (2016) Neutrophils suppress intraluminal NK cell-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discov 6:630–649. 10.1158/2159-8290.CD-15-1157
121. Brinkmann V et al (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535. 10.1126/science.1092385
122. Cools-Lartigue J et al (2013) Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Investig. 10.1172/JCI67484
123. Park J et al (2016) Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med 8:361ra138. 10.1126/scitranslmed.aag1711
124. Tohme S et al (2016) Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res 76:1367–1380. 10.1158/0008-5472.CAN-15-1591
125. Sawai H et al (2003) Interleukin-1alpha enhances integrin alpha(6)beta(1) expression and metastatic capability of human pancreatic cancer. Oncology 65:167–173. 10.1159/000072343
126. Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W (1993) Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 177:1277–1286
127. Bates RC, Mercurio AM (2003) Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 14:1790–1800. 10.1091/mbc.E02-09-0583
128. Voronov E et al (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100:2645–2650. 10.1073/pnas.0437939100
129. Jing Y et al (2011) Tumor necrosis factor-alpha promotes tumor growth by inducing vascular endothelial growth factor. Cancer Investig 29:485–493. 10.3109/07357907.2011.597812
130. Sturm JW et al (2003) Influence of TNFA on the formation of liver metastases in a syngenic mouse model. Int J Cancer 107:11–21. 10.1002/ijc.11320
131. Yano S et al (2003) Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci 94:244–252
132. Belizon A et al (2006) Major abdominal surgery increases plasma levels of vascular endothelial growth factor: open more so than minimally invasive methods. Ann Surg 244:792–798. 10.1097/01.sla.0000225272.52313.e2
133. Shantha Kumara HM et al (2009) Colorectal resection, both open and laparoscopic-assisted, in patients with benign indications is associated with proangiogenic changes in plasma angiopoietin 1 and 2 levels. Surg Endosc 23:409–415. 10.1007/s00464-008-0132-5
134. Oosterling SJ et al (2008) Anti-beta1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces. Ann Surg 247:85–94. 10.1097/SLA.0b013e3181588583
135. Yung S, Chan TM (2009) Intrinsic cells: mesothelial cells—central players in regulating inflammation and resolution. Perit Dial Int 29(Suppl 2):S21–S27
136. Abramovitch R, Marikovsky M, Meir G, Neeman M (1998) Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI. Br J Cancer 77:440–447
137. O’Reilly MS et al (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285
138. O’Reilly MS et al (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315–328
139. Holmgren L, O’Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149–153
140. Lim C et al (2013) Hepatic ischemia-reperfusion increases circulating bone marrow-derived progenitor cells and tumor growth in a mouse model of colorectal liver metastases. J Surg Res 184:888–897. 10.1016/j.jss.2013.04.069
141. Govaert KM et al (2014) Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells. Ann Surg 259:750–759. 10.1097/SLA.0b013e318295c160
142. Sceneay J et al (2012) Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res 72:3906–3911. 10.1158/0008-5472.CAN-11-3873
143. Brivio F et al (1996) Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients. Oncology 53:263–268
144. Brivio F et al (2002) Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline. Hepatogastroenterology 49:385–387
145. Oosterling SJ et al (2006) Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients. Immunobiology 211:641–649. 10.1016/j.imbio.2006.06.010
146. Kutza J, Gratz I, Afshar M, Murasko DM (1997) The effects of general anesthesia and surgery on basal and interferon stimulated natural killer cell activity of humans. Anesth Analg 85:918–923
147. Liu G et al (2012) Effective modulation of CD4(+)CD25 (+ high) regulatory T and NK cells in malignant patients by combination of interferon-alpha and interleukin-2. Cancer Immunol Immunother 61:2357–2366. 10.1007/s00262-012-1297-2
148. Ladenstein R et al (2011) Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion. J Clin Oncol 29:441–448. 10.1200/JCO.2009.23.5465
149. Shimizu K et al (2012) Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 19:171–178. 10.1007/s00534-011-0437-y
150. Shimizu K et al (2014) Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma. Hum Vaccin Immunother 10:970–976
151. Aranda F et al (2014) Trial watch: adoptive cell transfer for anticancer immunotherapy. Oncoimmunology 3:e28344. 10.4161/onci.28344
152. Cata JP et al (2017) Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol 15:152. 10.1186/s12957-017-1220-6
153. Martin CR et al (2014) Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. PLoS ONE 9:e98773. 10.1371/journal.pone.0098773
154. Ueda T et al (2014) Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis. Crit Care Med 42:e288–e295. 10.1097/CCM.0000000000000162
155. Benish M et al (2008) Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 15:2042–2052. 10.1245/s10434-008-9890-5
156. Qadri SS et al (2005) Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition. Ann Thorac Surg 79:990–995. 10.1016/j.athoracsur.2004.07.042 (discussion 990–995)
157. Shaashua L et al (2017) Perioperative COX-2 and beta-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial. Clin Cancer Res 23:4651–4661. 10.1158/1078-0432.CCR-17-0152
158. Zhou L et al (2016) Propranolol attenuates surgical stress-induced elevation of the regulatory T cell response in patients undergoing radical mastectomy. J Immunol 196:3460–3469. 10.4049/jimmunol.1501677
159. Melhem-Bertrandt A et al (2011) Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol 29:2645–2652. 10.1200/JCO.2010.33.4441
160. Forget P et al (2010) Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg 110:1630–1635. 10.1213/ANE.0b013e3181d2ad07
161. van der Hage JA et al (2001) Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854. Eur J Cancer 37:2184–2193
162. Sertoli MR et al (1995) Randomized cooperative study of perioperative chemotherapy in breast cancer. J Clin Oncol 13:2712–2721. 10.1200/JCO.1995.13.11.2712
163. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T (1978) Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 41:2088–2098
164. Shantha Kumara HM et al (2009) Perioperative GMCSF limits the proangiogenic plasma protein changes associated with colorectal cancer resection. Eur J Surg Oncol 35:295–301. 10.1016/j.ejso.2008.07.012
165. NSCLC Meta-analysis Collaborative Group (2014) Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet 383:1561–1571. 10.1016/S0140-6736(13)62159-5
166. Nordlinger B et al (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14:1208–1215. 10.1016/S1470-2045(13)70447-9
167. Emmenegger U, Kerbel RS (2010) Cancer: chemotherapy counteracted. Nature 468:637–638. 10.1038/468637a